TMB Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
TMB Capital Partners's LLY Position: Q2 2026 in Review
TMB Capital Partners reduced its Eli Lilly (LLY) stake by 0.49% in Q2 2026, selling an estimated $2.04K and leaving 410 shares worth $492K. The position accounts for 0.15% of the portfolio, ranked #111.
TMB Capital Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,613 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- TMB Capital Partners held 410 shares of Eli Lilly worth $492K as of Q2 2026.
- TMB Capital Partners sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
- Eli Lilly made up 0.15% of TMB Capital Partners's portfolio in Q2 2026, its #111 holding.
- TMB Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,613 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on TMB Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.